| Rossari Biotech Ltd |
|
Registered Office:
201 A-B 2nd Floor LBS Marg,Akruti Corporate Park Kanjur(W
,
Mumbai
-
400079
,
Maharashtra
, India.
Phone :
91-22-6123 3800 Fax:91-22-2579 6982
Email : cs@rossarimail.com
Website : www.rossari.com
|
Initial Public Offering of 11,676,470 equity shares of face value of  2 each ("equity shares") of Rossari Biotech Limited (the "company" or the "issuer") for cash at a price of 425 per equity share (including a share premium of 423 per equity share) (the "offer price") aggregating to 496.25 Crores comprising a fresh issue of 1,176,470 equity shares aggregating to 50* Crores (the "fresh issue") and an offer for sale of 10,500,000 equity shares (the "offered shares") aggregating to 44.63 Crores, comprising an offer for sale of 5,250,000 equity shares aggregating to 22.31 Crores by Mr. Edward Menezes and 5,250,000 equity shares aggregating to 22.31 Crores by Mr. Sunil Chari (the "promoter selling shareholders" or the "selling shareholders"), (the "offer for sale", and together with the fresh issue, the "offer"). The offer shall constitute 22.49% of the post-offer paid up equity share capital of the company.
The company has, in consultation with the book running lead managers ("brlms"), undertaken a private placement of equity shares aggregating to 99.999 Crores ("pre-ipo placement"). The size of the fresh issue of up to 150 Crores has been reduced by 99.999 Crores pursuant to the pre-ipo placement and accordingly, the size of the fresh issue is up to 50. Crores
|
| Issue |
Money Payable On |
|
| Opens On |
Closes On |
Application |
Allotment |
|
| 13-Jul-20 |
15-Jul-20 |
Rs425.00-0.00 |
Rs0.00-0.00 |
| Minimum Application for shares in Nos :35 Further Multiples of :35 |
| |
RsCr |
Lead Managers to the Issue |
|
| Project Cost |
0.00 |
|
| Project Financed through Current Offer |
496.25 |
|
| Post Issue Equity Share Capital |
10.39 |
|
| Issue Price |
Rs425.00 |
|
|